Belpomme header

Sickness due to exposure to electromagnetic radiation can now be objectively medically diagnosed and treated. That is the conclusion of the French oncologist Belpomme during the presentation of his investigation last February in Paris. He estimates that 1 to 10% of European citizens have reported a serious over-sensitivity to electromagnetic radiation generated by, for example, mobile phones, wireless devices, Wi-Fi and electrical apparatus. This specific over-sensitivity has been labelled as Electro Hypersensitivity (EHS).

There is much controversy about radiation being the cause of health problems and sickness. Many lands do not recognise EHS as a functional disturbance that can lead to work-related problems. Although the World Health Organisation (WHO) has acknowledged since 2004 that exposure to electromagnetic fields can have a negative impact on personal health.

Belpomme investigated 1216 patients who themselves indicated that they suffered from EHS and MCS (Multiple Chemical Sensitivity). He made brain scans and ultrasound images, and analysed blood and urine samples. Belpomme’s conclusion was that electromagnetic fields disturb the protective blood-brain barrier. This can lead to brain infections and oxidative stress; which can, in turn, lead to conditions such as Alzheimer, Parkinson or MS, and also schizophrenia, autism and bipolarity. He also discovered distinctive biomarkers in the blood: these are specific indicators that point to a certain condition or illness.

The treatment proposed by Belpomme for EHS sufferers appears similar to that for auto-immune illnesses. It comprises the recovery of the blood supply to the brain, increasing levels of vitamins, antihistamines en antioxidants. And the reduction of exposure to electromagnetic fields.

Professor Belpomme made a plea, during his presentation, to recognise Electro Hypersensitivity (EHS) as a medical complaint and a functional work-related health risk. Belpomme works as a lecturer in oncology at the University of Paris and is an oncologist in the Paris University Hospital. He is also chairman of the European Cancer and Environment Research Institute (ECERI) and is founder and chairman of the Association for Research on Treatment against Cancer (ARTAC). He is internationally recognised for his cancer research and his campaign against environmental pollution.